已收盤 09-12 16:00:00 美东时间
+0.580
+3.90%
今日重点评级关注:瑞银:上调Gossamer Bio评级至"买入",目标价从1.25美元升至9美元;Canaccord Genuity:维持Corcept Therapeutics"买入"评级,目标价从137美元升至140美元
09-11 10:06
Aeluma shares are trading lower after the company reported Q4 financial results...
09-11 01:00
Benchmark analyst David Williams reiterates Aeluma (NASDAQ:ALMU) with a Buy and maintains $25 price target.
09-10 22:54
Aeluma (NASDAQ:ALMU) sees FY2026 sales of $4.000 million-$6.000 million vs $7.350 million analyst estimate.
09-10 05:08
Gainers Wearable Devices (NASDAQ:WLDS) shares moved upwards by 118.6% to $2.23...
09-10 05:05
Aeluma (NASDAQ:ALMU) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 85.71 percent increase over losses of $(0.07) per share from the same period last year. The company
09-10 04:33
Companies Reporting Before The Bell • Core & Main (NYSE:CNM) is projected t...
09-09 16:32
Aeluma (NASDAQ:ALMU) Monday named Christopher Stewart as its new Chief Financial Officer. Stewart will be responsible for leading the company's finance organization and driving operational excellence ...
08-04 19:49
Benchmark analyst David Williams initiates coverage on Aeluma (NASDAQ:ALMU) with a Buy rating and announces Price Target of $25.
07-23 18:47
Craig-Hallum analyst Richard Shannon initiates coverage on Aeluma (NASDAQ:ALMU) with a Buy rating and announces Price Target of $26.
07-14 22:21